Company type | Public (TSX has Delisted this Stock) |
---|---|
Industry | Biotechnology |
Headquarters | , |
Key people | Mark Perrin |
Products | Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC) |
Number of employees | 44[ citation needed][ needs update] |
Website | www.conjuchem.com |
ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Quebec, Canada [1] which is credited with inventing the experimental peptide hormone CJC-1295. [2] [3]
It employs 45 people, 90% of whom are in research and development.[ citation needed][ needs update]